Trials / Conditions / Lower Limb Ischemia

Lower Limb Ischemia

14 registered clinical trials studyying Lower Limb Ischemia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Can the BeatMove Device Help Patients With Obliterative Arterial Disease of the Lower Limbs? NCT06226844	Centre Hospitalier Universitaire de Nīmes	N/A
Active Not Recruiting	The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry) NCT06416644	Hospital do Divino Espírito Santo de Ponta Delgada	N/A
Unknown	Endovascular Management of Combined Common Femoral and Superficial Femoral Arteries Lesions NCT05569369	Sohag University	N/A
Completed	Lower Limb Tissue Oxygenation Using Near-infrared Spectroscopy During Hallux Valgus Operation NCT04533035	Kuopio University Hospital	—
Unknown	Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to NCT04277702	Jagiellonian University	Phase 3
Completed	TeleEducation for Implementing a Clinical Practice Guideline For Amputees NCT05601349	Grupo Rehabilitacion en Salud	N/A
Completed	Lower Limb Surveillance During VA-ECLS NCT03910062	Central Hospital, Nancy, France	—
Unknown	Acute Limb Ischaemia (ALI) Management With 'Indigo' Mechanical Aspiration System NCT03295539	Lancashire Care NHS Foundation Trust	N/A
Unknown	An Efficacy and Safety Study to Evaluate Ranger DEB for BTK Angioplasty in Patients With CLI (RANGER-BTK) NCT02856230	Assistance Publique - Hôpitaux de Paris	Phase 2 / Phase 3
Withdrawn	Use Art-assist and Neupogen to Treat Chronic Limb Ischemia NCT02408991	University of Chicago	Phase 4
Unknown	Stem Cell Therapy for Patients With Vascular Occlusive Diseases Such as Diabetic Foot NCT02304588	Chinese PLA General Hospital	Phase 1
Completed	Non-Interventional Post Marketing Surveillance Study of Neovasculgen® in Patients With Chronic Lower Limb Isch NCT02369809	Artgen Biotech	Phase 4
Unknown	Autologous Bone Marrow Mononuclear Cells Therapy in Diabetic Lower Limb Ischemia NCT01937416	Hebei Medical University	Phase 1
Unknown	Feasibility Study of the TGI Adipose-derived Stromal Cell (ASC)-Coated ePTFE Vascular Graft NCT01305863	Tissue Genesis	N/A